These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Management of Barrett's esophagus: cases and questions. Bresalier R Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421 [TBL] [Abstract][Full Text] [Related]
24. Adiposity and columnar-lined esophagus. Lenglinger J; Eisler M; Riegler FM Am J Gastroenterol; 2008 May; 103(5):1316-7. PubMed ID: 18477363 [No Abstract] [Full Text] [Related]
25. Gastro-oesophageal reflux: the disease of the millennium. Navaratnam RM; Winslet MC Hosp Med; 1998 Aug; 59(8):646-9. PubMed ID: 9829061 [TBL] [Abstract][Full Text] [Related]
26. Barrett's esophagus: what do we really know about this disease? Fennerty MB Am J Gastroenterol; 1997 Jan; 92(1):1-3. PubMed ID: 8995929 [No Abstract] [Full Text] [Related]
27. The value of surveillance and other unresolved issues in the management of Barrett's esophagus. Playford RJ Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):60-1. PubMed ID: 16265103 [No Abstract] [Full Text] [Related]
29. Should people with Barrett's esophagus, who are at risk for cancer of the esophagus, avoid alcohol? Enzinger PC Health News; 2004 Jun; 10(6):16. PubMed ID: 15199910 [No Abstract] [Full Text] [Related]
31. Treatment of Barrett's esophagus with high-grade dysplasia. McAllaster JD; Buckles D; Al-Kasspooles M Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509 [TBL] [Abstract][Full Text] [Related]
32. The approach to high grade dysplasia in Barrett's esophagus. Case CL; Barkin JS Am J Gastroenterol; 2002 Jun; 97(6):1559-60. PubMed ID: 12094886 [No Abstract] [Full Text] [Related]
33. Should we worry about the length of Barrett's esophagus? Shaheen NJ Gastrointest Endosc; 2005 Nov; 62(5):682-5. PubMed ID: 16246679 [No Abstract] [Full Text] [Related]
34. Histology of metaplasia and dysplasia in Barrett's esophagus. Yerian L Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733 [TBL] [Abstract][Full Text] [Related]
37. Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis--experimental model in Wistar female rats. Melo LL; Kruel CD; Kliemann LM; Cavazzola LT; Boeno Rda L; Silber PC; Grossi RS Dis Esophagus; 1999; 12(2):106-15. PubMed ID: 10466042 [TBL] [Abstract][Full Text] [Related]
38. Epidemiology of the complications of gastroesophageal reflux disease. Belhocine K; Galmiche JP Dig Dis; 2009; 27(1):7-13. PubMed ID: 19439954 [TBL] [Abstract][Full Text] [Related]
39. Focus on Barrett's esophagus and esophageal adenocarcinoma. Paulson TG; Reid BJ Cancer Cell; 2004 Jul; 6(1):11-6. PubMed ID: 15261138 [No Abstract] [Full Text] [Related]
40. Antireflux surgery and Barrett's esophagus regression: wheel of fortune, or to tell the truth? Sampliner R Am J Gastroenterol; 1991 May; 86(5):645-6. PubMed ID: 2028963 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]